×


Orlistat Market - Size, Share & Outlook | Latest Developments

Orlistat Market by Service Type ( 120 mg, 60 mg ), Application ( Weight Reducing Aid, Others ), Vertical, and Region - Global Forecast to 2027

  • Report ID : IMR-15751 |
  • Category : Healthcare  |
  • Published Date : June 2021 |
  • Format :   IMR Report Formats   IMR Report Formats   IMR Report Formats

Global Orlistat Market Overview

The Orlistat market size is valued at USD 2,850.07 (M USD) in 2020 and is projected to grow to USD 4,348.26 (M USD) by 2027 with a CAGR of 6.2%. 

The growing number of weight-loss awareness initiatives is likely to be a significant driver for the growth of Orlistat market. Mainly, orlistat is used as an anti-obesity medication. The primary function of Orlistat is to inhibit fat absorption from the human diet. It limits fat absorption by acting as a lipase inhibitor, resulting in a reduction in calorie intake. Orlistat works by blocking pancreatic and gastric lipases, which are enzymes in the gut that break down triglycerides. When lipase activity is inhibited, dietary triglycerides are not digested into absorbable-free fatty acids and instead stay unaltered.

In most of the regions across globe, obesity-related issues have been a growing concern in the recent years. Orlistat also lowers blood pressure and inhibits the formation of type 2 diabetes in obese population. Orlistat medication does not allow an individual to regain lost weight and does not block the absorption of fats from non-fat foods and sugar.

Major Growth Drivers: Orlistat Market

Over the forecasted period, a robust pipeline of the orlistat drug is projected to enhance market growth. Furthermore, Orlistat, developed by the University of Texas South Western Medical Center, has been in phase 2 testing since 2015. Orlistat is a medication used to treat type 1 hyperlipoproteinemia. Lipoprotein lipase deficiency causes hyperlipoproteinemia type 1. The University of Texas South Western Medical Center's SLx-4090 is under phase 2 testing to see how well it works in conjunction with Orlistat. SLx-4090 is used to treat elevated blood fat levels, which are most commonly seen in people with hyperlipoproteinemia type 1.

The rising prevalence of obesity and its related diseases is projected to drive orlistat market expansion. According to a National Family Health Survey done in 2015 in India, over 9.8 million men and over 20 million women are obese. India has the world's second-highest rate of obese children, with the number steadily growing by 3-5 million patients per year.

Challenges : Orlistat Market

Health risks such as the risk of psychiatric disorder and stroke are expected to have a negative impact on market growth over the forecast period. Innumerable anti-obesity drugs approved in the last decade, including Knoll and Acomplia (rimonabant), have been withdrawn due to long-term side effects such as suicidal thoughts, depression, and cardiovascular problems. Due to the previously mentioned factors, healthcare providers have a negative impression of anti-obesity drugs and do not recommend them to consumers.

The market for orlistat and anti-obesity drugs is expected to grow slowly due to high attrition rates in the recent years. The transition of therapeutic goods from phase one through market is difficult because more than 80% of drugs are discontinued before reaching pre-registration. It will result in a low number of representative drugs in later stages of development.

Market Segmentation

By Type, Orlistat has been segmented into:

  • 120 mg
  • 60 mg

By Application, Orlistat has been segmented into:

  • Weight Reducing Aid
  • Others

Regions and Countries Level Analysis:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)

Geographically, Asia-Pacific accounted for the largest market share in 2017 and is anticipated to maintain its dominance by the end of 2023. Asia-Pacific is expected to exhibit the highest CAGR of 6.3% over the forecast period.

Players Covered in Orlistat market are :

  • Roche
  • GSK group
  • Teva
  • Sandoz(Novartis)
  • STADA-VN J.V.Co. Ltd
  • Hexal AG
  • National Company for Pharmaceutical Industry
  • Lunan Pharmaceutical Group Corporation
  • ZEIN pharmaceutical
  • HISUN
  • Taj Pharmaceuticals Ltd
  • Kabir Life Sciences & Research
  • DM Pharma
  • China Zhongshan Pharm

Frequently Asked Questions :

  • The forecast period in the market research report is 2021-2027.

  • The key players mentioned are Roche, GSK group, Teva,Sandoz(Novartis),STADA-VN J.V.Co. Ltd,Hexal AG,National Company for Pharmaceutical Industry,Lunan Pharmaceutical Group Corporation,ZEIN pharmaceutical,HISUN,Taj Pharmaceuticals Ltd,Kabir Life Sciences & Research,DM Pharma,China Zhongshan Pharm.

  • The Orlistat market is segmented into application type, product type and region. By Application type, the market is categorized into Weight Reducing Aid, Others. By product type, it is classified into 120 mg, 60 mg and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).

  • Geographically, Asia-Pacific accounted for the largest market share in 2017 and is anticipated to maintain its dominance by the end of 2023. Asia-Pacific is expected to exhibit the highest CAGR of 6.3% over the forecast period.

  • The Orlistat market size is valued at USD 2,850.07 (M USD) in 2020 and is projected to grow to USD 4,348.26 (M USD) by 2027 with a CAGR of 6.2%.

1. Market Overview of Orlistat
	1.1 Orlistat Market Overview
		1.1.1 Orlistat Product Scope
		1.1.2 Market Status and Outlook
	1.2 Orlistat Market Size by Regions: 2015 VS 2021 VS 2026
	1.3 Orlistat Historic Market Size by Regions (2015-2020)
	1.4 Orlistat Forecasted Market Size by Regions (2021-2026)
	1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
		1.5.1 North America
		1.5.2 East Asia
		1.5.3 Europe
		1.5.4 South Asia
		1.5.5 Southeast Asia
		1.5.6 Middle East
		1.5.7 Africa
		1.5.8 Oceania
		1.5.9 South America
		1.5.10 Rest of the World
	1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
		1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
		1.6.2 Covid-19 Impact: Commodity Prices Indices
		1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Orlistat Sales Market by Type (2015-2026)
	2.1 Global Orlistat Historic Market Size by Type (2015-2020)
	2.2 Global Orlistat Forecasted Market Size by Type (2021-2026)
	2.3 120 mg
	2.4 60 mg
3. Covid-19 Impact Orlistat Sales Market by Application (2015-2026)
	3.1 Global Orlistat Historic Market Size by Application (2015-2020)
	3.2 Global Orlistat Forecasted Market Size by Application (2021-2026)
	3.3 Weight Reducing Aid
	3.4 Others
4. Covid-19 Impact Market Competition by Manufacturers
	4.1 Global Orlistat Production Capacity Market Share by Manufacturers (2015-2020)
	4.2 Global Orlistat Revenue Market Share by Manufacturers (2015-2020)
	4.3 Global Orlistat Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Orlistat Business
	5.1 Roche
		5.1.1 Roche Company Profile
		5.1.2 Roche Orlistat Product Specification
		5.1.3 Roche Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.2 GSK group
		5.2.1 GSK group Company Profile
		5.2.2 GSK group Orlistat Product Specification
		5.2.3 GSK group Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.3 Teva
		5.3.1 Teva Company Profile
		5.3.2 Teva Orlistat Product Specification
		5.3.3 Teva Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.4 Sandoz(Novartis)
		5.4.1 Sandoz(Novartis) Company Profile
		5.4.2 Sandoz(Novartis) Orlistat Product Specification
		5.4.3 Sandoz(Novartis) Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.5 STADA-VN J.V.Co. Ltd
		5.5.1 STADA-VN J.V.Co. Ltd Company Profile
		5.5.2 STADA-VN J.V.Co. Ltd Orlistat Product Specification
		5.5.3 STADA-VN J.V.Co. Ltd Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.6 Hexal AG
		5.6.1 Hexal AG Company Profile
		5.6.2 Hexal AG Orlistat Product Specification
		5.6.3 Hexal AG Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.7 National Company for Pharmaceutical Industry
		5.7.1 National Company for Pharmaceutical Industry Company Profile
		5.7.2 National Company for Pharmaceutical Industry Orlistat Product Specification
		5.7.3 National Company for Pharmaceutical Industry Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.8 Lunan Pharmaceutical Group Corporation
		5.8.1 Lunan Pharmaceutical Group Corporation Company Profile
		5.8.2 Lunan Pharmaceutical Group Corporation Orlistat Product Specification
		5.8.3 Lunan Pharmaceutical Group Corporation Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.9 ZEIN pharmaceutical
		5.9.1 ZEIN pharmaceutical Company Profile
		5.9.2 ZEIN pharmaceutical Orlistat Product Specification
		5.9.3 ZEIN pharmaceutical Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.10 HISUN
		5.10.1 HISUN Company Profile
		5.10.2 HISUN Orlistat Product Specification
		5.10.3 HISUN Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.11 Taj Pharmaceuticals Ltd
		5.11.1 Taj Pharmaceuticals Ltd Company Profile
		5.11.2 Taj Pharmaceuticals Ltd Orlistat Product Specification
		5.11.3 Taj Pharmaceuticals Ltd Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.12 Kabir Life Sciences & Research
		5.12.1 Kabir Life Sciences & Research Company Profile
		5.12.2 Kabir Life Sciences & Research Orlistat Product Specification
		5.12.3 Kabir Life Sciences & Research Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.13 DM Pharma
		5.13.1 DM Pharma Company Profile
		5.13.2 DM Pharma Orlistat Product Specification
		5.13.3 DM Pharma Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
	5.14 China Zhongshan Pharm
		5.14.1 China Zhongshan Pharm Company Profile
		5.14.2 China Zhongshan Pharm Orlistat Product Specification
		5.14.3 China Zhongshan Pharm Orlistat Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
	6.1 North America Orlistat Market Size (2015-2026)
	6.2 North America Orlistat Key Players in North America (2015-2020)
	6.3 North America Orlistat Market Size by Type (2015-2020)
	6.4 North America Orlistat Market Size by Application (2015-2020)
7. East Asia
	7.1 East Asia Orlistat Market Size (2015-2026)
	7.2 East Asia Orlistat Key Players in North America (2015-2020)
	7.3 East Asia Orlistat Market Size by Type (2015-2020)
	7.4 East Asia Orlistat Market Size by Application (2015-2020)
8. Europe
	8.1 Europe Orlistat Market Size (2015-2026)
	8.2 Europe Orlistat Key Players in North America (2015-2020)
	8.3 Europe Orlistat Market Size by Type (2015-2020)
	8.4 Europe Orlistat Market Size by Application (2015-2020)
9. South Asia
	9.1 South Asia Orlistat Market Size (2015-2026)
	9.2 South Asia Orlistat Key Players in North America (2015-2020)
	9.3 South Asia Orlistat Market Size by Type (2015-2020)
	9.4 South Asia Orlistat Market Size by Application (2015-2020)
10. Southeast Asia
	10.1 Southeast Asia Orlistat Market Size (2015-2026)
	10.2 Southeast Asia Orlistat Key Players in North America (2015-2020)
	10.3 Southeast Asia Orlistat Market Size by Type (2015-2020)
	10.4 Southeast Asia Orlistat Market Size by Application (2015-2020)
11. Middle East
	11.1 Middle East Orlistat Market Size (2015-2026)
	11.2 Middle East Orlistat Key Players in North America (2015-2020)
	11.3 Middle East Orlistat Market Size by Type (2015-2020)
	11.4 Middle East Orlistat Market Size by Application (2015-2020)
12. Africa
	12.1 Africa Orlistat Market Size (2015-2026)
	12.2 Africa Orlistat Key Players in North America (2015-2020)
	12.3 Africa Orlistat Market Size by Type (2015-2020)
	12.4 Africa Orlistat Market Size by Application (2015-2020)
13. Oceania
	13.1 Oceania Orlistat Market Size (2015-2026)
	13.2 Oceania Orlistat Key Players in North America (2015-2020)
	13.3 Oceania Orlistat Market Size by Type (2015-2020)
	13.4 Oceania Orlistat Market Size by Application (2015-2020)
14. South America
	14.1 South America Orlistat Market Size (2015-2026)
	14.2 South America Orlistat Key Players in North America (2015-2020)
	14.3 South America Orlistat Market Size by Type (2015-2020)
	14.4 South America Orlistat Market Size by Application (2015-2020)
15. Rest of the World
	15.1 Rest of the World Orlistat Market Size (2015-2026)
	15.2 Rest of the World Orlistat Key Players in North America (2015-2020)
	15.3 Rest of the World Orlistat Market Size by Type (2015-2020)
	15.4 Rest of the World Orlistat Market Size by Application (2015-2020)
16 Orlistat Market Dynamics
	16.1 Covid-19 Impact Market Top Trends
	16.2 Covid-19 Impact Market Drivers
	16.3 Covid-19 Impact Market Challenges
	16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
	18.1 Research Methodology
		18.1.1 Methodology/Research Approach
		18.1.2 Data Source
	18.2 Disclaimer
Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2015-2020
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2015-2020
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2015-2020
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2015-2020
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2015-2020
Table Major Players
Table Major Production Market share by Players 2019
Table Major Revenue (M USD) Market share by Players 2019
Table Production Market share by Major Regions in 2015-2020
Table Production Market share by Major Regions in 2021-2026
Table Revenue (M USD) Market share by Regions in 2015-2020
Table Revenue (M USD) Market share by Regions in 2021-2026
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2015-2020
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Roche Information List
Figure Orlistat Picture, Specifications and Applications of Roche
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table GSK group Information List
Figure Orlistat Picture, Specifications and Applications of GSK group
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Teva Information List
Figure Orlistat Picture, Specifications and Applications of Teva
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Sandoz(Novartis) Information List
Figure Orlistat Picture, Specifications and Applications of Sandoz(Novartis)
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table STADA-VN J.V.Co. Ltd Information List
Figure Orlistat Picture, Specifications and Applications of STADA-VN J.V.Co. Ltd
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Hexal AG Information List
Figure Orlistat Picture, Specifications and Applications of Hexal AG
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table National Company for Pharmaceutical Industry Information List
Figure Orlistat Picture, Specifications and Applications of National Company for Pharmaceutical Industry
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Lunan Pharmaceutical Group Corporation Information List
Figure Orlistat Picture, Specifications and Applications of Lunan Pharmaceutical Group Corporation
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table ZEIN pharmaceutical Information List
Figure Orlistat Picture, Specifications and Applications of ZEIN pharmaceutical
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table HISUN Information List
Figure Orlistat Picture, Specifications and Applications of HISUN
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Taj Pharmaceuticals Ltd Information List
Figure Orlistat Picture, Specifications and Applications of Taj Pharmaceuticals Ltd
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Kabir Life Sciences & Research Information List
Figure Orlistat Picture, Specifications and Applications of Kabir Life Sciences & Research
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table DM Pharma Information List
Figure Orlistat Picture, Specifications and Applications of DM Pharma
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table China Zhongshan Pharm Information List
Figure Orlistat Picture, Specifications and Applications of China Zhongshan Pharm
Table Orlistat Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits
Table Business Locations
Figure Supply channels
Figure marketing strategy
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value (M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value (M USD)
Table China Supply, Import, Export, Consumption and Consumption Value (M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value (M USD)
Table India Supply, Import, Export, Consumption and Consumption Value (M USD)
Table World Demand by Regions Forecast Analysis of Orlistat (2021-2026)
Table World Price by Regions Forecast Analysis of Orlistat (2021-2026)
Table World Price by Types Forecast Analysis of Orlistat (2021-2026)
Table World Price by Applications Forecast Analysis of Orlistat (2021-2026)
Table World Revenue (M USD) by Regions Forecast Analysis of Orlistat (2021-2026)
Table World Revenue (M USD) by Types Forecast Analysis of Orlistat (2021-2026)
Table World Revenue (M USD) by Applications Forecast Analysis of Orlistat (2021-2026)
LICENSE TYPE
NEW YEAR SALE!! UPTO 30% OFF

Inquiry Before Buying


SPECIAL PRICES

For startups and educational institutions.

Request Discount 

CUSTOMIZATION

IMR offers custom market research services as per customer requirements.

Request Customization 




Why Choose Us


Reliable Market Service

We provide accurate market insights and effective consulting to achieve your goals.


Holistic Market View

We provide in-depth knowledge of the market which enables our clients to take informed decisions at minimum risks.


Innovative Methodology

Our world class researchers use big data and advanced analytics to not only provide accurate insights, but spot future trends and help you you grow.


Customer Centric

We strive to deliver deep understanding of the elements which are pivotal to prosperity of our clients.


24/7 Support

Our dedicated support team is here to help you in every aspect.


Introspective Market Research
Loading....Please Wait